Hide metadata

dc.date.accessioned2022-12-22T17:41:09Z
dc.date.available2022-12-22T17:41:09Z
dc.date.created2022-05-06T13:38:42Z
dc.date.issued2022
dc.identifier.citationSu, Zhangli Monshaugen, Ida Wilson, Briana Wang, Fengbin Klungland, Arne Ougland, Rune Dutta, Anindya . TRMT6/61A-dependent base methylation of tRNA-derived fragments regulates gene-silencing activity and the unfolded protein response in bladder cancer. Nature Communications. 2022, 13(1)
dc.identifier.urihttp://hdl.handle.net/10852/98325
dc.description.abstractAbstract RNA modifications are important regulatory elements of RNA functions. However, most genome-wide mapping of RNA modifications has focused on messenger RNAs and transfer RNAs, but such datasets have been lacking for small RNAs. Here we mapped N 1 -methyladenosine (m 1 A) in the cellular small RNA space. Benchmarked with synthetic m 1 A RNAs, our workflow identified specific groups of m 1 A-containing small RNAs, which are otherwise disproportionally under-represented. In particular, 22-nucleotides long 3′ tRNA-fragments are highly enriched for TRMT6/61A-dependent m 1 A located within the seed region. TRMT6/61A-dependent m 1 A negatively affects gene silencing by tRF-3s. In urothelial carcinoma of the bladder, where TRMT6/61A is over-expressed, higher m 1 A modification on tRFs is detected, correlated with a dysregulation of tRF targetome. Lastly, TRMT6/61A regulates tRF-3 targets involved in unfolded protein response. Together, our results reveal a mechanism of regulating gene expression via base modification of small RNA.
dc.languageEN
dc.publisherNature Portfolio
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleTRMT6/61A-dependent base methylation of tRNA-derived fragments regulates gene-silencing activity and the unfolded protein response in bladder cancer
dc.title.alternativeENEngelskEnglishTRMT6/61A-dependent base methylation of tRNA-derived fragments regulates gene-silencing activity and the unfolded protein response in bladder cancer
dc.typeJournal article
dc.creator.authorSu, Zhangli
dc.creator.authorMonshaugen, Ida
dc.creator.authorWilson, Briana
dc.creator.authorWang, Fengbin
dc.creator.authorKlungland, Arne
dc.creator.authorOugland, Rune
dc.creator.authorDutta, Anindya
cristin.unitcode185,51,12,0
cristin.unitnameAvdeling for molekylærmedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.cristin2022132
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Nature Communications&rft.volume=13&rft.spage=&rft.date=2022
dc.identifier.jtitleNature Communications
dc.identifier.volume13
dc.identifier.issue1
dc.identifier.pagecount0
dc.identifier.doihttps://doi.org/10.1038/s41467-022-29790-8
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2041-1723
dc.type.versionPublishedVersion
cristin.articleid2165


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International